CAST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.322700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.984600E-01
Normal-vs-Stage2
9.408600E-04
Normal-vs-Stage3
7.857600E-01
Normal-vs-Stage4
7.535700E-02
Stage1-vs-Stage2
4.815400E-01
Stage1-vs-Stage3
5.663400E-01
Stage1-vs-Stage4
3.031600E-01
Stage2-vs-Stage3
2.549400E-01
Stage2-vs-Stage4
7.506400E-01
Stage3-vs-Stage4
1.506160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.681100E-03
Normal-vs-AfricanAmerican
3.627000E-01
Normal-vs-Asian
2.153600E-01
Caucasian-vs-AfricanAmerican
6.717200E-01
Caucasian-vs-Asian
9.955200E-01
AfricanAmerican-vs-Asian
6.241000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.143520E-03
Normal-vs-Female
2.793600E-02
Male-vs-Female
2.624400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.138600E-01
Normal-vs-Age(41-60Yrs)
1.630460E-04
Normal-vs-Age(61-80Yrs)
4.988200E-02
Normal-vs-Age(81-100Yrs)
8.636400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.271200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.831200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.867800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.722100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.894400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.065200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.835760E-01
Normal-vs-Daily Drinker
3.043000E-01
Normal-vs-Weekly Drinker
4.283800E-01
Normal-vs-Occasional Drinker
2.050400E-02
Normal-vs-Social Drinker
4.057200E-01
Non Drinker-vs-Daily Drinker
7.446600E-01
Non Drinker-vs-Weekly Drinker
8.415400E-01
Non Drinker-vs-Occasional Drinker
2.292800E-01
Non Drinker-vs-Social Drinker
8.994200E-01
Daily Drinker-vs-Weekly Drinker
9.420400E-01
Daily Drinker-vs-Occasional Drinker
1.177240E-01
Daily Drinker-vs-Social Drinker
8.020600E-01
Weekly Drinker-vs-Occasional Drinker
2.221000E-01
Weekly Drinker-vs-Social Drinker
8.966800E-01
Occasional Drinker-vs-Social Drinker
1.552220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.784400E-01
Normal-vs-Grade 2
2.994000E-02
Normal-vs-Grade 3
3.158000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.816000E-03
Grade 1-vs-Grade 3
2.567100E-04
Grade 1-vs-Grade 4
2.784400E-01
Grade 2-vs-Grade 3
3.216500E-02
Grade 2-vs-Grade 4
2.994000E-02
Grade 3-vs-Grade 4
3.158000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.179600E-02
Normal-vs-NonDiabetic
7.143900E-03
Diabetic-vs-NonDiabetic
7.763200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.370500E-02
Normal-vs-NoPancreatitis
8.337100E-03
Pancreatitis-vs-NoPancreatitis
6.774200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.574480E-02
Normal-vs-N1
1.497350E-03
N0-vs-N1
6.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.65017999999018E-05
Normal-vs-TP53-NonMutant
1.103790E-01
TP53-Mutant-vs-TP53-NonMutant
5.446400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
